{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:11:21Z","timestamp":1790611881803,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12920-018-0443-x","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T06:49:42Z","timestamp":1547016582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1"],"prefix":"10.1186","volume":"12","author":[{"given":"Sun Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Kwang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Chang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"issue":"7","key":"443_CR1","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1128\/JVI.01552-06","volume":"81","author":"MD Hyrcza","year":"2007","unstructured":"Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, Wilkins O, Ostrowski M, Der SD. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol. 2007;81(7):3477\u201386.","journal-title":"J Virol"},{"issue":"6","key":"443_CR2","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1128\/JVI.01846-10","volume":"85","author":"F Vigneault","year":"2011","unstructured":"Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, Church G, Martinez-Picado J, Rosenberg ES, et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol. 2011;85(6):3015\u20139.","journal-title":"J Virol"},{"issue":"2","key":"443_CR3","doi-asserted-by":"publisher","first-page":"e55791","DOI":"10.1371\/journal.pone.0055791","volume":"8","author":"J Yang","year":"2013","unstructured":"Yang J, Yang Z, Lv H, Lou Y, Wang J, Wu N. Bridging HIV-1 cellular latency and clinical long-term non-Progressor: an Interactomic view. PLoS One. 2013;8(2):e55791.","journal-title":"PLoS One"},{"issue":"1","key":"443_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2010.12.037","volume":"411","author":"M Salgado","year":"2011","unstructured":"Salgado M, L\u00f3pez-Romero P, Callejas S, L\u00f3pez M, Labarga P, Dopazo A, Soriano V, Rod\u00e9s B. Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression. Virology. 2011;411(1):103\u201312.","journal-title":"Virology"},{"issue":"2","key":"443_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.virol.2012.10.026","volume":"435","author":"JQ Wu","year":"2013","unstructured":"Wu JQ, Sasse TR, Wolkenstein G, Conceicao V, Saksena MM, Soedjono M, Perera SS, Wang B, Dwyer DE, Saksena NK. Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology. 2013;435(2):308\u201319.","journal-title":"Virology"},{"issue":"1","key":"443_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12967-017-1294-5","volume":"15","author":"LL Zhang","year":"2017","unstructured":"Zhang LL, Zhang ZN, Wu X, Jiang YJ, Fu YJ, Shang H. Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease. J Transl Med. 2017;15(1):191.","journal-title":"J Transl Med"},{"issue":"9","key":"443_CR7","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1371\/journal.pmed.0050184","volume":"5","author":"A Ramasamy","year":"2008","unstructured":"Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008;5(9):e184.","journal-title":"PLoS Med"},{"issue":"9","key":"443_CR8","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1093\/nar\/gkr1265","volume":"40","author":"GC Tseng","year":"2012","unstructured":"Tseng GC, Ghosh D, Feingold E. Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res. 2012;40(9):3785\u201399.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"443_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/bioinformatics\/btm620","volume":"24","author":"F Hong","year":"2008","unstructured":"Hong F, Breitling R. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Bioinformatics. 2008;24(3):374\u201382.","journal-title":"Bioinformatics"},{"issue":"1","key":"443_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"443_CR11","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1093\/bioinformatics\/btx292","volume":"33","author":"F Carratore Del","year":"2017","unstructured":"Del Carratore F, Jankevics A, Eisinga R, Heskes T, Hong F, Breitling R. RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets. Bioinformatics. 2017;33(17):2774\u20135.","journal-title":"Bioinformatics"},{"key":"443_CR12","volume-title":"R Foundation for Statistical Computing","author":"Team RC","year":"2018","unstructured":"Team RC. R: A Language and Environment for statistical computing. In: R Foundation for Statistical Computing; 2018. \n                    http:\/\/www.r-project.org\/\n                    \n                  ."},{"issue":"7","key":"443_CR13","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"443_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/1471-2105-7-359","volume":"7","author":"IB Jeffery","year":"2006","unstructured":"Jeffery IB, Higgins DG, Culhane AC. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics. 2006;7(1):359.","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"443_CR15","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8(9):R183.","journal-title":"Genome Biol"},{"issue":"1","key":"443_CR16","first-page":"25","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M. Gene ontology: tool for the unification of. Biology. 2000;25(1):25\u20139.","journal-title":"Biology"},{"key":"443_CR17","doi-asserted-by":"crossref","unstructured":"Poropatich K, Sullivan DJ, Jr. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J Gen Virol. 2011;92(Pt 2):247-68","DOI":"10.1099\/vir.0.027102-0"},{"key":"443_CR18","doi-asserted-by":"crossref","unstructured":"Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009;5(12):e1000791.","DOI":"10.1371\/journal.pgen.1000791"},{"key":"443_CR19","doi-asserted-by":"crossref","unstructured":"Limou S, Zagury JF. Immunogenetics: Genome-wide association of non-progressive HIV and viral load control: HLA genes and beyond. Front Immunol. 2013;4:118-118.","DOI":"10.3389\/fimmu.2013.00118"},{"key":"443_CR20","doi-asserted-by":"crossref","unstructured":"Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M et al. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis. 2010;202(6):908-15.","DOI":"10.1086\/655782"},{"key":"443_CR21","doi-asserted-by":"crossref","unstructured":"Tsiara CG, Nikolopoulos GK, Dimou NL, Pantavou K, Bagos P, Mensah B, Talias M, Braliou G, Paraskeva D, Bonovas S et al. Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis. 2018;97.","DOI":"10.1007\/s12041-018-0907-y"},{"key":"443_CR22","doi-asserted-by":"crossref","unstructured":"Williams B, Landay A, Presti RM. Microbiome alterations in HIV infection a review. Cell Microbiol. 2016;18(5):645-51.","DOI":"10.1111\/cmi.12588"},{"key":"443_CR23","doi-asserted-by":"crossref","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365.","DOI":"10.1038\/nm1511"},{"key":"443_CR24","doi-asserted-by":"crossref","unstructured":"Nowak P, Troseid M, Avershina E, Barqasho B, Neogi U, Holm K, Hov JR, Noyan K, Vesterbacka J, Svard J et al. Gut microbiota diversity predicts immune status in HIV-1 infection. Aids. 2015;29(18):2409-18.","DOI":"10.1097\/QAD.0000000000000869"},{"key":"443_CR25","doi-asserted-by":"crossref","unstructured":"Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM, Huang Y, Somsouk M et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013;5(193):193ra191-193ra191.","DOI":"10.1126\/scitranslmed.3006438"},{"issue":"2","key":"443_CR26","doi-asserted-by":"publisher","first-page":"e02338","DOI":"10.1128\/mBio.02338-17","volume":"9","author":"C Casado","year":"2018","unstructured":"Casado C, Marrero-Hernandez S, Marquez-Arce D, Pernas M, Marfil S, Borras-Granana F, Olivares I, Cabrera-Rodriguez R, Valera MS, de Armas-Rillo L, et al. Viral characteristics associated with the clinical Nonprogressor phenotype are inherited by viruses from a cluster of HIV-1 elite controllers. mBio. 2018;9(2):e02338.","journal-title":"mBio"},{"issue":"7","key":"443_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0945-053X(00)00107-4","volume":"19","author":"H Chen","year":"2000","unstructured":"Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol. 2000;19(7):597\u2013614.","journal-title":"Matrix Biol"},{"key":"443_CR28","doi-asserted-by":"publisher","first-page":"296069","DOI":"10.1155\/2011\/296069","volume":"2011","author":"Z Lopez-Dee","year":"2011","unstructured":"Lopez-Dee Z, Pidcock K, Gutierrez LS. Thrombospondin-1: multiple paths to inflammation. Mediat Inflamm. 2011;2011:296069.","journal-title":"Mediat Inflamm"},{"key":"443_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/sj.cdd.4401582","volume":"12","author":"P Matarrese","year":"2005","unstructured":"Matarrese P, Malorni W. Human immunodeficiency virus (HIV)-1 proteins and cytoskeleton: partners in viral life and host cell death. Cell Death Differ. 2005;12:932.","journal-title":"Cell Death Differ"},{"issue":"4","key":"443_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2007.09.046","volume":"363","author":"DR Fontenot","year":"2007","unstructured":"Fontenot DR, den Hollander P, Vela EM, Newman R, Sastry JK, Kumar R. Dynein light chain 1 peptide inhibits human immunodeficiency virus infection in eukaryotic cells. Biochem Biophys Res Commun. 2007;363(4):901\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"443_CR31","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1128\/JVI.03347-14","volume":"89","author":"KD Jayappa","year":"2015","unstructured":"Jayappa KD, Ao Z, Wang X, Mouland AJ, Shekhar S, Yang X, Yao X. Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein. J Virol. 2015;89(7):3497\u2013511.","journal-title":"J Virol"},{"issue":"3","key":"443_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.intimp.2012.07.015","volume":"14","author":"M Liu","year":"2012","unstructured":"Liu M, Zhao J, Chen K, Bian X, Wang C, Shi Y, Wang JM. G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma. Int Immunopharmacol. 2012;14(3):283\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"443_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1074-7613(00)80484-7","volume":"4","author":"CG Park","year":"1996","unstructured":"Park CG, Lee SY, Kandala G, Lee SY, Choi Y. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity. 1996;4(6):583\u201391.","journal-title":"Immunity"},{"issue":"30","key":"443_CR34","doi-asserted-by":"publisher","first-page":"29469","DOI":"10.18632\/oncotarget.5177","volume":"6","author":"L Ren","year":"2015","unstructured":"Ren L, Mendoza A, Zhu J, Briggs JW, Halsey C, Hong ES, Burkett SS, Morrow JJ, Lizardo MM, Osborne T, et al. Characterization of the metastatic phenotype of a panel of established osteosarcoma cells. Oncotarget. 2015;6(30):29469\u201381.","journal-title":"Oncotarget"},{"issue":"20","key":"443_CR35","first-page":"5920","volume":"62","author":"R Neef","year":"2002","unstructured":"Neef R, Kuske MA, Prols E, Johnson JP. Identification of the human PHLDA1\/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res. 2002;62(20):5920\u20139.","journal-title":"Cancer Res"},{"issue":"9","key":"443_CR36","doi-asserted-by":"publisher","first-page":"e106349","DOI":"10.1371\/journal.pone.0106349","volume":"9","author":"G Li","year":"2014","unstructured":"Li G, Wang X, Hibshoosh H, Jin C, Halmos B. Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 mutations and PHLDA1. PLoS One. 2014;9(9):e106349.","journal-title":"PLoS One"},{"issue":"3","key":"443_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/br.2016.580","volume":"4","author":"MA Nagai","year":"2016","unstructured":"Nagai MA. Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer. Biomedical Reports. 2016;4(3):275\u201381.","journal-title":"Biomedical Reports"},{"issue":"6","key":"443_CR38","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1074\/jbc.M117.778399","volume":"293","author":"S Magi","year":"2018","unstructured":"Magi S, Iwamoto K, Yumoto N, Hiroshima M, Nagashima T, Ohki R, Garcia-Munoz A, Volinsky N, Von Kriegsheim A, Sako Y, et al. Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization. J Biol Chem. 2018;293(6):2206\u201318.","journal-title":"J Biol Chem"},{"issue":"5","key":"443_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.chom.2008.10.004","volume":"4","author":"H Zhou","year":"2008","unstructured":"Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008;4(5):495\u2013504.","journal-title":"Cell Host Microbe"},{"key":"443_CR40","doi-asserted-by":"publisher","first-page":"24090","DOI":"10.1038\/srep24090","volume":"6","author":"A Kumar","year":"2016","unstructured":"Kumar A, Abbas W, Colin L, Khan KA, Bouchat S, Varin A, Larbi A, Gatot J-S, Kabeya K, Vanhulle C, et al. Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci Rep. 2016;6:24090.","journal-title":"Sci Rep"},{"key":"443_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4690-5-11","volume":"5","author":"P Chugh","year":"2008","unstructured":"Chugh P, Bradel-Tretheway B, Monteiro-Filho CM, Planelles V, Maggirwar SB, Dewhurst S, Kim B. Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy. Retrovirology. 2008;5:11.","journal-title":"Retrovirology"},{"key":"443_CR42","unstructured":"Cheng G, Ji C, Yang N, Meng L, Ding Y, Wei J. RNA-binding protein RBM38: acting as a tumor suppressor in colorectal cancer, vol. 9; 2016."},{"key":"443_CR43","doi-asserted-by":"crossref","unstructured":"Shu L, Yan W, Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev. 2006;20(21):2961-72.","DOI":"10.1101\/gad.1463306"},{"key":"443_CR44","doi-asserted-by":"crossref","unstructured":"Zhang J, Cho SJ, Shu L, Yan W, Guerrero T, Kent M, Skorupski K, Chen H, Chen X. Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas. Genes Dev. 2011;25(14):1528-43.","DOI":"10.1101\/gad.2069311"},{"key":"443_CR45","doi-asserted-by":"crossref","unstructured":"de Pablo A, Bogoi R, Bejarano I, Toro C, Valencia E, Moreno V, Martin-Carbonero L, Gomez-Hernando C, Rodes B. Short communication: p21\/CDKN1A expression shows broad interindividual diversity in a subset of HIV-1 elite controllers. AIDS Res Hum Retroviruses. 2016;32(3):232-36.","DOI":"10.1089\/aid.2015.0137"},{"key":"443_CR46","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez N, Greenwell-Wild T, Marinos NJ, Swaim WD, Nares S, Ott DE, Schubert U, Henklein P, Orenstein JM, Sporn MB et al. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol. 2005;79(7):4479-91.","DOI":"10.1128\/JVI.79.7.4479-4491.2005"},{"key":"443_CR47","doi-asserted-by":"crossref","unstructured":"Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y et al. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest. 2011;121(4):1549-60.","DOI":"10.1172\/JCI44539"},{"key":"443_CR48","doi-asserted-by":"crossref","unstructured":"Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kloszewska I et al. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. Neurobiology of aging. 2014;35(2):279-90.","DOI":"10.1016\/j.neurobiolaging.2013.08.002"},{"key":"443_CR49","doi-asserted-by":"crossref","unstructured":"Ma J, Zhang W, Tan L, Wang H-F, Wan Y, Sun F-R, Tan C-C, Yu J-T, Tan L, Alzheimer's Disease Neuroimaging I. MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures. Oncotarget 2016, 7(37):58779-88.","DOI":"10.18632\/oncotarget.9563"},{"key":"443_CR50","doi-asserted-by":"crossref","unstructured":"Denner J, Eschricht M, Lauck M, Semaan M, Schlaermann P, Ryu H, Akyuz L. Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1. PLoS One. 2013;8(1):e55199.","DOI":"10.1371\/journal.pone.0055199"},{"issue":"2","key":"443_CR51","doi-asserted-by":"publisher","first-page":"e1000781","DOI":"10.1371\/journal.ppat.1000781","volume":"6","author":"M Rotger","year":"2010","unstructured":"Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, Shianna KV, Ge D, Gunthard HF, Goldstein DB, et al. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 2010;6(2):e1000781.","journal-title":"PLoS Pathog"},{"issue":"6","key":"443_CR52","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1172\/JCI45235","volume":"121","author":"M Rotger","year":"2011","unstructured":"Rotger M, Dalmau J, Rauch A, McLaren P, Bosinger SE, Martinez R, Sandler NG, Roque A, Liebner J, Battegay M, et al. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest. 2011;121(6):2391\u2013400.","journal-title":"J Clin Invest"},{"issue":"17","key":"443_CR53","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1128\/JVI.01046-14","volume":"88","author":"MJ Buzon","year":"2014","unstructured":"Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol. 2014;88(17):10056\u201365.","journal-title":"J Virol"},{"issue":"4","key":"443_CR54","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1128\/JVI.02228-07","volume":"82","author":"AR Sedaghat","year":"2008","unstructured":"Sedaghat AR, German J, Teslovich TM, Cofrancesco J Jr, Jie CC, Talbot CC Jr, Siliciano RF. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J Virol. 2008;82(4):1870\u201383.","journal-title":"J Virol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-018-0443-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T19:07:25Z","timestamp":1578510445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0443-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0443-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"3"}}